You are here: Industry Insights > Endometriosis

News List

Organon to Acquire Forendo Pharma AmericanPharmaceuticalReview
November 12, 2021
Organon and Forendo Pharma announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company...
Debiopharm and Dexa Medica Launch Triptorelin Collaboration to Bring New Hope to Women With Endometriosis prnasia
October 13, 2021
Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin...
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData expresspharma
March 30, 2021
Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively.
Is Women’s Health gaining momentum? expresspharma
March 09, 2021
In Express Pharma’s Women’s Day Special issue, some industry observers and pharma stakeholders share insights on opportunities, challenges and focus on the women’s health segment as it continues to evolve and advance.
FOR-6219 shows promise in Phase I endometriosis trial contractpharma
March 04, 2021
FOR-6219 was found to be safe and well tolerated by healthy pre- and postmenopausal women and did not induce systemic oestrogen deficiency-related side effects.
Is Your Pelvic Pain a Sign of Endometriosis? drugs
September 16, 2019
Women with pelvic pain should consider the possibility of endometriosis and discuss it with their doctor, an expert in gynecology says.
Endometriosis Tied to Adverse Pregnancy Outcomes drugs
August 12, 2019
Laparoscopically confirmed endometriosis is associated with several adverse pregnancy outcomes, according to a study published online in Obstetrics & Gynecology.
FOGSI and Bayer launch care guidelines on endometriosis for doctors expressbpd
June 27, 2019
VISION (Valuable Insights in Indian Endometriosis- Redefining Outcomes) will help address the challenges faced by physicians in the field of endometriosis
New test could diagnose nine in 10 endometriosis cases pharmatimes
April 04, 2019
Currently, the average time for an endometriosis diagnosis can be as long as seven years, including a long and painful process as patients need to go undergo keyhole surgery to identify tissues around the ovaries and fallopian tubes in order to get proper
FDA approves AbbVie’s Orilissa for endometriosis pain pharmaceutical-technology
July 26, 2018
The US Food and Drug Administration (FDA) has approved AbbVie and Neurocrine Biosciences’ drug Orilissa (elagolix) for women with moderate to severe endometriosis pain.

Previous page 1 2 Next page